Multiprotein-based nanomedicines with dual CD44/CD133 targeting and GSH-responsive drug release for improving cancer chemotherapy. - Yu LY; Shueng PW; Wang YH; Yen YW; Chen KW; Li CR; Chiu HC; Lin YW; Lo CL (Drug delivery and translational research, 2026)